Medtronic plc (FRA:2M6)
Germany
· Delayed Price · Currency is EUR | Market Cap | 111.70B |
| Revenue (ttm) | 29.88B |
| Net Income (ttm) | 4.10B |
| Shares Out | n/a |
| EPS (ttm) | 3.17 |
| PE Ratio | 27.27 |
| Forward PE | 17.26 |
| Dividend | 2.54 (2.90%) |
| Ex-Dividend Date | Sep 26, 2025 |
| Volume | n/a |
| Average Volume | 782 |
| Open | 87.49 |
| Previous Close | 87.53 |
| Day's Range | 87.49 - 87.49 |
| 52-Week Range | 68.50 - 91.45 |
| Beta | n/a |
| RSI | 55.36 |
| Earnings Date | Nov 18, 2025 |
About Medtronic
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair produc... [Read more]
Financial Performance
In 2025, Medtronic's revenue was $33.54 billion, an increase of 3.62% compared to the previous year's $32.36 billion. Earnings were $4.66 billion, an increase of 26.82%.
Financial numbers in USD Financial StatementsNews
The US Rollout of MiniMed 780G With Abbott's Sensor May Lift MDT Stock
Medtronic begins the U.S. rollout of MiniMed 780G with Abbott's Instinct sensor, advancing diabetes care.
Medtronic (MDT) Launches MiniMed 780G System with Instinct Sensor in the U.S.
Medtronic (MDT) Launches MiniMed 780G System with Instinct Sensor in the U.S.
Medtronic begins U.S. commercial launch of the MiniMed™ 780G system with the Instinct sensor, made by Abbott
GALWAY, Ireland , Dec. 2, 2025 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the broad U.S. commercial launch of the MiniMed™ 780G system integrated...
3 Stocks to Buy and Hold: the Long-Term Play for Your Portfolio
Intuitive Surgical shows why now is a good time to consider buying surgical-robot competitor Medtronic. Eli Lilly helps explain why down-and-out drugmaker Pfizer could be worth a close look for long-t...
Best Dividend Aristocrats For December 2025
The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has underperformed the SPDR S&P 500 ETF (SPY) year-to-date, but November shows a reversal. Several Dividend Aristocrats, including CAH, CAT, CHRW,...
Robotics can 'democratize good healthcare' worldwide: Medtronic CEO
Medtronic Chairman and CEO Geoffrey Martha discusses the company's latest robotic innovation and how robotics can impact healthcare on 'The Claman Countdown.' #fox #media #us #usa #new #news #foxbusin...
Congressional Trading Report: Sen. Tina Smith Sold Over $100K In Huntington Bancshares Stock
A November filing shows that Senator Tina Smith reported a sale in Huntington Bancshares (NASDAQ: HBAN), valued between $100,001 and $250,000. The transaction date is listed as November 21, 2025, wit...
Decoding Medtronic PLC (MDT): A Strategic SWOT Insight
Decoding Medtronic PLC (MDT): A Strategic SWOT Insight
Relative Strength Soars On Medtronic Stock. Here's How To Get Bullish
The bull call spread takes advantage of low implied volatility for a bullish trade with less risk.
Balancing Act: Why Healthcare Can’t Choose Between AI Innovation And Sustainability
NORTHAMPTON, MA / ACCESS Newswire / November 24, 2025 / Raman Venkatesh, Medtronic Chief Sustainability Officer, and Rodolphe Katra, Medtronic Chief Artificial Intelligence (AI) Officer, on how we can...
5 Top Dividend Stocks to Buy in November
For investors, it's generally wise to buy and hold companies that continually raise their dividends. There are deals in energy, healthcare, consumer staples, and even the tech space.
ISRG vs. MDT: A High-Tech Robotics Faceoff in the Race for Leadership
Intuitive Surgical's robotics surge and Medtronic's broad innovation push set the stage for a high-tech showdown in next-gen minimally invasive care.
This Medtech Giant's Stock Is Soaring. Should You Buy It Ahead of 2026?
Medtronic is proving that it's a reliable company to invest in.
Which 'Dividend Prince' Will Become The Next King In 2 Years?
Medtronic is nearing a crowning achievement.
What Are the Best Healthcare Stocks to Buy Now? I Think It's Intuitive Surgical (ISRG) -- or, to Play It Safer, Medtronic (MDT)
Robotic surgery is a hot field, with new entrants coming.
Notable healthcare headlines for the week: Abbott, Medtronic, Merck and J&J in focus
MDT Quantitative Stock Analysis
Below is Validea's guru fundamental report for MEDTRONIC PLC (MDT). Of the 22 guru strategies we follow, MDT rates highest using our Multi-Factor Investor model based on the published strategy of Pim ...
Notable analyst calls this week: Dell, Medtronic and T-Mobile among top picks
Insider Sell: Gregory Smith Sells 30,000 Shares of Medtronic PLC
Insider Sell: Gregory Smith Sells 30,000 Shares of Medtronic PLC
2 Fantastic Dividend Stocks to Buy and Hold Forever
Abbott and Medtronic are innovative healthcare leaders that generate consistent revenue and profits. They also have attractive long-term prospects and have consistently raised their dividend payouts.
Barclays Raises Medtronic (MDT) Price Target, Maintains Overweight Rating | MDT Stock News
Barclays Raises Medtronic (MDT) Price Target, Maintains Overweight Rating | MDT Stock News
Medtronic (MDT) Analyst Rating Update: Price Target Raised to $110 | MDT Stock News
Medtronic (MDT) Analyst Rating Update: Price Target Raised to $110 | MDT Stock News
Medtronic (MDT) Stock Signal: Should You Sell the Price Spike? - 20 November 2025
A strong earnings report led to a post-earnings spike, despite muted revenue guidance and declining profit margins. Should you sell the price spike?
MDT Factor-Based Stock Analysis
Below is Validea's guru fundamental report for MEDTRONIC PLC (MDT). Of the 22 guru strategies we follow, MDT rates highest using our Multi-Factor Investor model based on the published strategy of Pim ...
These Analysts Increase Their Forecasts On Medtronic After Strong Q2 Earnings
Medtronic Plc (NYSE: MDT) on Tuesday reported strong second- quarter 2026 results . The company’s sales reached $8.96 billion, surpassing the consensus estimate of $8.87 billion. This marks a 6.6% in...